Iovance Biotherapeutics
Amjad Naimi is a skilled professional in the pharmaceutical and biotechnology sectors, currently serving as a Raw Materials Supervisor at Iovance Biotherapeutics, Inc. since May 2025. Prior experience includes roles as a Chemistry Supervisor at Hikma Pharmaceuticals from August 2022 to May 2025 and as an Analytical Research Supervisor at MS PHARMA from April 2018 to April 2022, where responsibilities encompassed method development and validation for drug products. Amjad also held positions as an Analytical Research Chemist and Quality Control Microbiologist at Hikma Pharmaceuticals, focusing on analytical methods and microbiological testing. Earlier career steps involved working as a Medical Representative at IDS and a Laboratory Technician at MedLabs Consultancy Group. Amjad earned a Bachelor's Degree in Medical Laboratory Sciences from Jordan University of Science and Technology between 2005 and 2010.
Previous companies
This person is not in any teams
This person is not in any offices
Iovance Biotherapeutics
6 followers
Iovance Biotherapeutics (NASDAQ: IOVA) aims to improve patient care for people living with cancer. Iovance is investigating T cell-based therapies, known as tumor infiltrating lymphocytes (TIL), which use a patient’s own immune cells to attack cancer.